Bausch Health Companies Inc Share Price Toronto S.E.
Equities
CA91911K1021
Pharmaceuticals
Sales 2024 * | 9.4B 12.85B 784B | Sales 2025 * | 9.67B 13.22B 807B | Capitalization | 2.62B 3.58B 218B |
---|---|---|---|---|---|
Net income 2024 * | 148M 202M 12.36B | Net income 2025 * | 389M 532M 32.47B | EV / Sales 2024 * | 2.45 x |
Net Debt 2024 * | 20.44B 27.96B 1,706B | Net Debt 2025 * | 19.09B 26.12B 1,594B | EV / Sales 2025 * | 2.25 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
6.77
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.62% |
Latest transcript on Bausch Health Companies Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 24/22/24 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 01/08/01 |
John Paulson
CHM | Chairman | 68 | 01/17/01 |
Steven Miller
BRD | Director/Board Member | 35 | 17/21/17 |
1st Jan change | Capi. | |
---|---|---|
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |